^
    BIOMARKER:

    MET overexpression

    i
    Other names: DFNB97, AUTS9, RCCP2, C-Met, HGFR, HGF Receptor, Met Proto-Oncogene, HGF/SF Receptor, Proto-Oncogene C-Met, Scatter Factor Receptor, Tyrosine-Protein Kinase Met, Hepatocyte Growth Factor Receptor, MET, MET Proto-Oncogene, Receptor Tyrosine Kinase




    Show legend

    Include preclinical:
    Non Small Cell Lung Cancer
    Gastric Cancer
    Hepatocellular Cancer
    Squamous Cell Carcinoma of Head and Neck
    Lung Non-Squamous Non-Small Cell Cancer
    Melanoma
    Colorectal Cancer
    Glioblastoma
    Pancreatic Cancer
    Adrenal Cortex Carcinoma
    Lung Adenocarcinoma
    MYTX-011
    tepotinib
    ARQ 197
    SCC244
    ABBV-399
    crizotinib
    savolitinib
    BPI-9016M
    REGN5093
    cetuximab + AV-299
    osimertinib + savolitinib
    erlotinib + ARQ 197
    SHR-A1403
    vemurafenib
    bevacizumab
    cetuximab
    trametinib + dabrafenib
    TR1801-ADC
    cabozantinib capsule
    CKD-702
    S95027
    WXSH0011
    crizotinib + chidamide
    MG132
    BRAF inhibitor + MEK inhibitor
    EGFR inhibitor
    Immunotherapy